<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="3-part\PMC7092853\results\search\tropicalVirus\results.xml">
  <result pre="Communications0006-291X1090-2104Elsevier Inc. pmcid: 7092853S0006-291X(19)32332-0 doi: 10.1016/j.bbrc.2019.12.012 : Article Cephalotaxine inhibits" exact="Zika" post="infection by impeding viral replication and stability LaiZheng-ZongabcHoYi-Jungde∗∗LuJeng-Weijengweilu@gmail.comf∗[a], [b],"/>
  <result pre="long as the COVID-19 resource centre remains active. Abstract The" exact="Zika" post="virus (ZIKV) is a mosquito-borne flavivirus that has reemerged"/>
  <result pre="an alkaloid isolated from Cephalotaxus drupacea, was effective in inhibiting" exact="ZIKV" post="activity in vitro (i.e., in Vero and A549 cell"/>
  <result pre="decrease in viral replication. Specifically, CET was found to decrease" exact="ZIKV" post="RNA and viral protein expression, inhibit ZIKV replication, and"/>
  <result pre="found to decrease ZIKV RNA and viral protein expression, inhibit" exact="ZIKV" post="replication, and inhibit ZIKV mRNA/protein production. We also determined"/>
  <result pre="RNA and viral protein expression, inhibit ZIKV replication, and inhibit" exact="ZIKV" post="mRNA/protein production. We also determined that CET is effective"/>
  <result pre="could be an effective lead compound in the treatment of" exact="ZIKV" post="and also suggest that further investigation and development of"/>
  <result pre="to a new class of anti-Flavivirus medications. Highlights •CET against" exact="ZIKV" post="infection via inhibiting replication and stability. •CET was identified"/>
  <result pre="and stability. •CET was identified as a potent inhibitor of" exact="ZIKV" post="infection. •CET as a candidate compound for potential ZIKV"/>
  <result pre="of ZIKV infection. •CET as a candidate compound for potential" exact="ZIKV" post="treatment. Keywords Antiviral Cephalotaxine Viral production Replication Dengue virus"/>
  <result pre="for potential ZIKV treatment. Keywords Antiviral Cephalotaxine Viral production Replication" exact="Dengue" post="virus Zika virus 1 Introduction The Zika virus (ZIKV)"/>
  <result pre="ZIKV treatment. Keywords Antiviral Cephalotaxine Viral production Replication Dengue virus" exact="Zika" post="virus 1 Introduction The Zika virus (ZIKV) is a"/>
  <result pre="Viral production Replication Dengue virus Zika virus 1 Introduction The" exact="Zika" post="virus (ZIKV) is a mosquito-borne, enveloped RNA virus that"/>
  <result pre="family (a family to which the Hepatitis C virus (HCV]," exact="Dengue" post="virus (DENV], West Nile virus (WNV], Yellow fever virus"/>
  <result pre="to which the Hepatitis C virus (HCV], Dengue virus (DENV]," exact="West Nile" post="virus (WNV], Yellow fever virus [YFV], and Japanese encephalitis"/>
  <result pre="C virus (HCV], Dengue virus (DENV], West Nile virus (WNV]," exact="Yellow fever" post="virus [YFV], and Japanese encephalitis virus [JEV] also belong.)"/>
  <result pre="fever virus [YFV], and Japanese encephalitis virus [JEV] also belong.)" exact="ZIKV" post="was first isolated from rhesus monkeys near the Zika"/>
  <result pre="belong.) ZIKV was first isolated from rhesus monkeys near the" exact="Zika" post="Forest in Uganda in 1947 [1,2]. The viral genome"/>
  <result pre="Forest in Uganda in 1947 [1,2]. The viral genome of" exact="ZIKV" post="encodes a polyprotein which consists of a capsid, a"/>
  <result pre="NS3, NS4A, NS4 B, and NS5 [3]. In recent years," exact="ZIKV" post="infection has become a serious and escalating threat to"/>
  <result pre="a serious and escalating threat to global health. For example," exact="ZIKV" post="spread rapidly in 2015 in at least 33 regions"/>
  <result pre="between 0.5 and 1.5 million people [[4], [5], [6], [7]]." exact="ZIKV" post="infection has been associated with several neurological complications, such"/>
  <result pre="which affected Brazil and other Central and South American countries," exact="ZIKV" post="infection was only considered to lead only to a"/>
  <result pre="as well as neurological and ocular abnormalities. In some cases," exact="ZIKV" post="during pregnancy can even led to perinatal death [10]."/>
  <result pre="ZIKV during pregnancy can even led to perinatal death [10]." exact="ZIKV" post="is also known to cause a benign febrile illness"/>
  <result pre="which are similar to those of other arbovirus infections, including" exact="DENV" post="and the chikungunya virus (CHIKV). Specifically, these symptoms include"/>
  <result pre="headaches, vomiting and jaundice [11]. Other clinical symptoms typical of" exact="ZIKV" post="infection include fever, headaches, joint pain, conjunctivitis, and macular"/>
  <result pre="[12]. In February 2016, the World Health Organization (WHO) declared" exact="ZIKV" post="to be a Public Health Emergency of International Concern"/>
  <result pre="Health Emergency of International Concern (PHEIC) [13]. Strategies of fighting" exact="ZIKV" post="infection include the development of vaccines and the screening"/>
  <result pre="of the viral life cycle [14]. Unfortunately, no approved antiviral" exact="ZIKV" post="agents are currently available. There is thus an urgent"/>
  <result pre="urgent need to develop safe and effective antiviral agents against" exact="ZIKV" post="and to elucidate their mechanisms. Doing so should help"/>
  <result pre="treatment of other diseases, including some cancers [18]. HT inhibits" exact="CHIKV" post="replication by down-regulating viral protein expression, while HHT shows"/>
  <result pre="that CET (1) disrupts the viral life cycle by preventing" exact="ZIKV" post="from replicating and (2) exhibits virucidal activity against ZIKV."/>
  <result pre="ATCC® CCL-185™) cells, as these cells are more permissive to" exact="ZIKV" post="(PRAVABC59, ATCC® VR-1843™) replication. Both Vero and A549 cells"/>
  <result pre="concentrations of CET, and 400 foci forming units (FFUs) of" exact="ZIKV" post="were added to the cells. Following incubation for another"/>
  <result pre="titers contained therein were determined using IFA. Relative quantifications of" exact="ZIKV" post="RNA in Vero cells were determined using quantitative reverse"/>
  <result pre="co-treatment group, CET was added at the initial point of" exact="ZIKV" post="infection. (3) For the post-treatment group, CET was added"/>
  <result pre="infection. (3) For the post-treatment group, CET was added after" exact="ZIKV" post="infection. (4) For the pre-treatment group, CET was added"/>
  <result pre="For the pre-treatment group, CET was added 3 h before" exact="ZIKV" post="infection. Following ZIKV infection, Vero cells in all treatment"/>
  <result pre="group, CET was added 3 h before ZIKV infection. Following" exact="ZIKV" post="infection, Vero cells in all treatment groups were incubated"/>
  <result pre="The cell-free anti-ZIKV activity of CET was investigated by incubating" exact="ZIKV" post="suspensions containing 5 × 104 FFU with indicated concentrations"/>
  <result pre="considered significant [[22], [23], [24]]. 3 Results 3.1 CET inhibited" exact="ZIKV" post="infection Earlier research found that CET was able to"/>
  <result pre="seeded in 12-well plates overnight and were then infected with" exact="ZIKV" post="at 1500 FFU per well. After 48 h of"/>
  <result pre="1500 FFU per well. After 48 h of incubation with" exact="ZIKV" post="and indicated concentrations of CET, cells were fixed and"/>
  <result pre="demonstrated that CET from 20 to 100 μM significantly inhibited" exact="ZIKV" post="infection in a dose-dependent manner (Fig. 1 A, B,"/>
  <result pre="(Fig. 1 A, B, and 1C). Fig. 1 CET inhibited" exact="ZIKV" post="infection. The inhibition of CET in ZIKV-infected Vero cells"/>
  <result pre="Statistical significance was determined via a t-test compared with the" exact="ZIKV" post="group: * indicates p &amp;lt; 0.05; ** indicates p"/>
  <result pre="0.01; and *** indicates p &amp;lt; 0.001. 3.2 CET inhibited" exact="ZIKV" post="production The viability of CET-treated Vero cells was determined"/>
  <result pre="measuring viral RNA levels, protein expression, and viral titers. (B)" exact="ZIKV" post="RNA levels were analyzed by qRT-PCR. (C) ZIKV protein"/>
  <result pre="titers. (B) ZIKV RNA levels were analyzed by qRT-PCR. (C)" exact="ZIKV" post="protein expression was detected by Western blotting. (D) Virus"/>
  <result pre="Statistical significance was determined via a t-test compared with the" exact="ZIKV" post="group: * indicates p &amp;lt; 0.05; ** indicates p"/>
  <result pre="were seeded in 12-well plates overnight, infected with 400 FFU" exact="ZIKV" post="per well, and incubated with indicated concentrations of CET"/>
  <result pre="assays were employed. Results of qRT-PCR showed that CET inhibited" exact="ZIKV" post="infection in a dose-dependent manner (Fig. 2B). In particular,"/>
  <result pre="100 μM CET was found to suppress approximately 98% of" exact="ZIKV" post="RNA production. Furthermore, Vero cells infected with 1000 FFU"/>
  <result pre="ZIKV RNA production. Furthermore, Vero cells infected with 1000 FFU" exact="ZIKV" post="per well under indicated dosages of CET for 48"/>
  <result pre="48 h incubation. Results of Western blotting analysis revealed that" exact="ZIKV" post="protein expression was significantly reduced under CET treatment (Fig."/>
  <result pre="of FFU assays revealed that CET is able to decrease" exact="ZIKV" post="progeny yield in a dose-dependent manner (Fig. 2D). Taken"/>
  <result pre="the above evidence indicates that CET is effective in suppressing" exact="ZIKV" post="propagation. 3.3 CET may affect ZIKV RNA replication and"/>
  <result pre="is effective in suppressing ZIKV propagation. 3.3 CET may affect" exact="ZIKV" post="RNA replication and stability Our data indicated that CET"/>
  <result pre="stability Our data indicated that CET is able to inhibit" exact="ZIKV" post="infection by decreasing viral RNA, protein, and progeny yield."/>
  <result pre="groups. (Cells in all groups were infected with 8000 FFU" exact="ZIKV" post="per well for 1 h) Following the end of"/>
  <result pre="analysis revealed that CET likely affects the late stage of" exact="ZIKV" post="infection (Fig. 3 A and B), which means that"/>
  <result pre="likely occur after virus entry. To investigate CET inhibition after" exact="ZIKV" post="entry, Vero cells were infected with ZIKV, washed with"/>
  <result pre="the post-treatment group were administered 40 or 80 μM CET," exact="ZIKV" post="RNA levels were significantly reduced (Fig. 3C). FFU assays"/>
  <result pre="in which cells were incubated with supernatant containing 50,000 FFU" exact="ZIKV" post="with or without 40 μM CET at room temperature"/>
  <result pre="(B) virus progeny production. The effects of administering CET after" exact="ZIKV" post="infection (i.e., the post-treatment group) as revealed by (C)"/>
  <result pre="Statistical significance was determined via a t-test compared with the" exact="ZIKV" post="group: * indicates p &amp;lt; 0.05, ** indicates p"/>
  <result pre="*** indicates p &amp;lt; 0.001. 4 Discussion The outbreak of" exact="ZIKV" post="in Brazil in 2015 was one of most uncontrollable"/>
  <result pre="most uncontrollable epidemics that the world has experienced. Since then," exact="ZIKV" post="has become a flavivirus of great medical concern. Nonetheless,"/>
  <result pre="and effective clinical compounds is critical for the treatment of" exact="ZIKV" post="patients and for the control of ZIKV outbreaks [25,26]."/>
  <result pre="the treatment of ZIKV patients and for the control of" exact="ZIKV" post="outbreaks [25,26]. CET and its derived ester compounds (such"/>
  <result pre="ester derivatives have inhibitory effects against HBV [16], VZV and" exact="CHIKV" post="[19,21]. However, this is the first study to demonstrate"/>
  <result pre="this is the first study to demonstrate that CET inhibits" exact="ZIKV" post="infection. Specifically, results of IFA revealed that CET treatment"/>
  <result pre="Moreover, HT has been found to limit the replication of" exact="CHIKV" post="by inhibiting large ribosomal subunits and subsequently down-regulating the"/>
  <result pre="addition assay showed that CET affected the late stage of" exact="ZIKV" post="infection (Fig. 3A and B). We further sought to"/>
  <result pre="sought to determine the possible mechanism by which CET influences" exact="ZIKV" post="RNA replication. Previous research which investigated VZV determined that"/>
  <result pre="which suggest that the primary mechanism by which CET inhibited" exact="ZIKV" post="involved viral replication, not virus release. However, the time"/>
  <result pre="summary, our data indicate that CET is able to inhibit" exact="ZIKV" post="infection by affecting both viral replication and viral stability."/>
  <result pre="four different dengue virus serotypes and found that CET reduced" exact="DENV" post="RNA levels in a Vero cell model, in which"/>
  <result pre="the further study of CET as a candidate compound for" exact="ZIKV" post="treatment. Declaration of Competing Interest None. References References 1DickG.W.KitchenS.F.HaddowA.J.Zika"/>
  <result pre="serological specificityTrans. R. Soc. Trop. Med. Hyg.46195250952012995440 2EspanoE.NamJ.H.SongE.J.SongD.LeeC.K.KimJ.K.Lipophilic statins inhibit" exact="Zika" post="virus production in Vero cellsSci. Rep.920191146131391514 3KunoG.ChangG.J.Full-length sequencing and"/>
  <result pre="Rep.920191146131391514 3KunoG.ChangG.J.Full-length sequencing and genomic characterization of Bagaza, Kedougou, and" exact="Zika" post="virusesArch. Virol.152200768769617195954 4PetersenL.R.JamiesonD.J.PowersA.M.HoneinM.A.Zika virusN. Engl. J. Med.37420161552156327028561 5HennesseyM.FischerM.StaplesJ.E.Zika virus"/>
  <result pre="2016MMWR Morb. Mortal. Wkly. Rep.652016555826820163 6TeixeiraM.G.Costa MdaC.de OliveiraW.K.NunesM.L.RodriguesL.C.The epidemic of" exact="Zika" post="virus-related microcephaly in Brazil: detection, control, etiology, and future"/>
  <result pre="early epidemiological and genetic findingsScience352201634534927013429 8LeeJ.L.LoeM.W.C.LeeR.C.H.ChuJ.J.H.Antiviral activity of pinocembrin against" exact="Zika" post="virus replicationAntivir. Res.1672019132430959074 9ChenJ.LiangY.YiP.XuL.HawkinsH.K.RossiS.L.SoongL.CaiJ.MenonR.SunJ.Outcomes of congenital Zika disease depend"/>
  <result pre="of pinocembrin against Zika virus replicationAntivir. Res.1672019132430959074 9ChenJ.LiangY.YiP.XuL.HawkinsH.K.RossiS.L.SoongL.CaiJ.MenonR.SunJ.Outcomes of congenital" exact="Zika" post="disease depend on timing of infection and maternal-fetal interferon"/>
  <result pre="Epidemiol. Rec.912016738126897760 14BatistaM.N.BragaA.C.S.CamposG.R.F.SouzaM.M.MatosR.P.A.LopesT.Z.CandidoN.M.LimaM.L.D.MachadoF.C.AndradeS.T.Q.BittarC.NogueiraM.L.CarneiroB.M.MariuttiR.B.ArniR.K.CalmonM.F.RahalP.Natural products isolated from oriental medicinal herbs inactivate" exact="Zika" post="virusViruses112019 15LuS.WangJ.Homoharringtonine and omacetaxine for myeloid hematological malignanciesJ. Hematol."/>
  <result pre="agent of chikungunya virus through multiple mechanismsAntivir. Res.159201813414230300716 23HoY.J.LuJ.W.HuangY.L.LaiZ.Z.Palmatine inhibits" exact="Zika" post="virus infection by disrupting virus binding, entry, and stabilityBiochem."/>
 </snippets>
</snippetsTree>
